Efficacy of first-line oxaliplatin-based chemotherapy regimens depending on the KRAS mutation status
M. Yu. Fedyanin, Kh. Kh.-M. El’snukaeva, I. A. Pokataev, A. A. Tryakin, A. A. Bulanov, O. V. Sekhina, D. A. Chekini, E. O. Ignatova, S. S. Gordeev, M. D. Budurova, Z. Mamedli, D. V. Podluzhnyy, N. A. Kozlov, S. A. Tyulyandin
Published in Тазовая хирургия и онкология (01.05.2018)
Published in Тазовая хирургия и онкология (01.05.2018)
Get full text
Journal Article